In vitro activity of Pheroid vesicles containing antibiotics against Plasmodium falciparum (Q41928024)

14 October 2017

title

In vitro activity of Pheroid vesicles containing antibiotics against Plasmodium falciparum (English)

1 reference

14 October 2017

0 references

Plasmodium falciparum

1 reference

inferred from title

author

Lissinda H du Plessis

object named as

Lissinda H Du Plessis

1

0 references

author name string

Anel C van Niekerk

2

1 reference

14 October 2017

Marlene M Maritz

3

1 reference

14 October 2017

Awie F Kotzé

4

1 reference

14 October 2017

publication date

24 October 2012

1 reference

The Journal of Antibiotics

14 October 2017

published in

1 reference

14 October 2017

volume

65

1 reference

14 October 2017

issue

12

1 reference

14 October 2017

page(s)

609-614

1 reference

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Design, synthesis, and in vitro activity of novel 2'-O-substituted 15-membered azalides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Antimalarial activity of 9a-N substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Design, synthesis and evaluation of 3-methylene-substituted indolinones as antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Aza vinyl sulfones: synthesis and evaluation as antiplasmodial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Analyzing a Potential Drug Target N-Myristoyltransferase of Plasmodium falciparum Through In Silico Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Design and in vitro haemolytic evaluation of cryptolepine hydrochloride-loaded gelatine nanoparticles as a novel approach for the treatment of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

In vitro evaluation of erythromycin in chloroquine resistant brazilian P. falciparum freshly isolates: modulating effect and antimalarial activity evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Efficacy of azithromycin as a causal prophylactic agent against murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Tolerability of azithromycin as malaria prophylaxis in adults in northeast papua, indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid™ technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Human malaria parasites in continuous culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using a Bayesian approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Malaria drug-sensitivity testing: new assays, new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Reversal of chloroquine resistance in Plasmodium falciparum by 9H-xanthene derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Triclosan is minimally effective in rodent malaria models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

Evaluation of the physical properties and stability of two lipid drug delivery systems containing mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

7 January 2021

Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

7 January 2021

Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

7 January 2021

Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

7 January 2021

Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.89

7 January 2021

Identifiers

DOI

10.1038/JA.2012.89

1 reference

Dimensions Publication ID

14 October 2017

1019366738

0 references

1 reference